Skip to main content
Earnings Labs
Novo Nordisk A/S logo

Novo Nordisk A/S (NVO)

NYSE·Healthcare·Drug Manufacturers - General

$51.57

+1.22%

Mkt Cap $176.82B

Analyst Ratings

Buy

0

Hold

2

Sell

0

Price Target (16 analysts)

$45.00

Range $45.00$45.00

Implied Upside

-12.7%

Consensus $45.00 vs current $51.57